Screening for Colorectal Cancer: Which Test can we Afford?

References

• 1 Martel G, Boushey R P. Laparoscopic colon surgery: past, present and future.  Surg Clin North Am. 2006;  86 867-897
• 2 Biasco G, Derenzini E, Grazi G. et al . Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.  Cancer Treat Rev. 2006;  32 214-28
• 3 Kemeny N. Management of liver metastases from colorectal cancer.  Oncology. 2006;  20 1161-1176, 1179; discussion 79 - 80, 85 - 86
• 4 Headrick J R, Miller D L, Nagorney D M. et al . Surgical treatment of hepatic and pulmonary metastases from colon cancer.  Ann Thorac Surg. 2001;  71 975-979; discussion 79 - 80
• 5 Daniels I R, Fisher S E, Heald R J. et al . Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.  Colorectal Dis. 2007;  9 290-301
• 6 Kapiteijn E, Marijnen C A, Nagtegaal I D. et al . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med. 2001;  345 638-646
• 7 Mazhar D, Stebbing J, Heller W. Recent advances in the systemic management of colorectal cancer.  Future Oncol. 2006;  2 643-650
• 8 Venook A. Critical evaluation of current treatments in metastatic colorectal cancer.  Oncologist. 2005;  10 250-261
• 9 Schrag D. The price tag on progress - chemotherapy for colorectal cancer.  N Engl J Med. 2004;  351 317-319
• 10 Aballea S, Chancellor J V, Raikou M. et al . Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.  Cancer. 2007;  109 1082-1089
• 11 Special report: fecal DNA analysis for colon cancer screening.  Technol Eval Cent Asses Program Exec Summ. 2006;  21 1-2
• 12 Kochman M L, Levin B. Expert commentary - virtual colonoscopy: utility as a screening test for colorectal cancer?.  MedGenMed. 2004;  6 21
• 13 Faivre J, Dancourt V, Lejeune C. et al . Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.  Gastroenterology. 2004;  126 1674-1680
• 14 Hardcastle J D, Chamberlain J O, Robinson M H. et al . Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.  Lancet. 1996;  348 1472-1477
• 15 Kronborg O, Fenger C, Olsen J. et al . Randomised study of screening for colorectal cancer with faecal-occult-blood test.  Lancet. 1996;  348 1467-1471
• 16 Mandel J S, Church T R, Ederer F. et al . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.  J Natl Cancer Inst. 1999;  91 434-437
• 17 Church T R, Ederer F, Mandel J S. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test.  J Natl Cancer Inst. 1997;  89 1440-1448
• 18 Gyrd-Hansen D, Sogaard J, Kronborg O. Analysis of screening data: colorectal cancer.  Int J Epidemiol. 1997;  26 1172-1181
• 19 Young G P, St John D J, Winawer S J. et al . Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.  Am J Gastroenterol. 2002;  97 2499-2507
• 20 Ouyang D L, Chen J J, Getzenberg R H. et al . Noninvasive testing for colorectal cancer: a review.  Am J Gastroenterol. 2005;  100 1393-1403
• 21 Hixson L J, Fennerty M B, Sampliner R E. et al . Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps.  Gastrointest Endosc. 1991;  37 125-127
• 22 Levin T R. Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted?.  Gastroenterol Clin North Am. 2002;  31 1015-1029, vii
• 23 Lieberman D A, Weiss D G. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.  N Engl J Med. 2001;  345 555-560
• 24 Rex D K, Cutler C S, Lemmel G T. et al . Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies.  Gastroenterology. 1997;  112 24-28
• 25 Rex D K, Rahmani E Y, Haseman J H. et al . Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice (see comments).  Gastroenterology. 1997;  112 17-23
• 26 Atkin W S, Edwards R, Wardle J. et al . Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening.  J Med Screen. 2001;  8 137-144
• 27 Prorok P C, Andriole G L, Bresalier R S. et al . Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.  Control Clin Trials. 2000;  21 273S-2309S
• 28 Hoff G, Sauar J, Vatn M H. et al . Polypectomy of adenomas in the prevention of colorectal cancer: 10 years’ follow-up of the Telemark Polyp Study I.  Scand J Gastroenterol. 1996;  31 1006-1010
• 29 Muller A D, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans.  Arch Intern Med. 1995;  155 1741-1748
• 30 Selby J V, Friedman G D, Quesenberry C P. et al . A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.  N Engl J Med. 1992;  326 653-657
• 31 Winawer S J, Zauber A G, Ho M N. et al . Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.  N Engl J Med. 1993;  329 1977-1981
• 32 Nicholson F B, Barro J L, Atkin Jr W. et al . Review article: Population screening for colorectal cancer.  Aliment Pharmacol Ther. 2005;  22 1069-1077
• 33 Maciosek M V, Solberg L I, Coffield A B. et al . Colorectal cancer screening: health impact and cost effectiveness.  Am J Prev Med. 2006;  31 80-89
• 34 Pignone M, Saha S, Hoerger T. et al . Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U. S. Preventive Services Task Force.  Ann Intern Med. 2002;  137 96-104
• 35 Song K, Fendrick A M, Ladabaum U. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.  Gastroenterology. 2004;  126 1270-1279
• 36 Frazier A L, Colditz G A, Fuchs C S. et al . Cost-effectiveness of screening for colorectal cancer in the general population.  Jama. 2000;  284 1954-1961
• 37 Khandker R K, Dulski J D, Kilpatrick J B. et al . A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults.  Int J Technol Assess Health Care. 2000;  16 799-810
• 38 Ness R M, Holmes A M, Klein R. et al . Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages.  Am J Gastroenterol. 2000;  95 1800-1811
• 39 Sonnenberg A, Delco F, Inadomi J M. Cost-effectiveness of colonoscopy in screening for colorectal cancer.  Ann Intern Med. 2000;  133 573-584
• 40 Vijan S, Hwang E W, Hofer T P. et al . Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.  Am J Med. 2001;  111 593-601
• 41 Winawer S, Fletcher R, Rex D. et al . Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.  Gastroenterology. 2003;  124 544-560
• 42 Winawer S J, Zauber A G, Fletcher R H. et al . Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.  Gastroenterology. 2006;  130 1872-1885
• 43 Atkin W S, Morson B C, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.  N Engl J Med. 1992;  326 658-662
• 44 Pignone M. Challenges in implementation of effective and efficient colon cancer screening.  Dig Liver Dis. 2007;  39 251-252
• 45 Tappenden P, Chilcott J, Eggington S. et al . Option appraisal of population-based colorectal cancer screening programmes in England.  Gut. 2007;  56 677-684
• 46 Hassan C, Zullo A, Laghi A. et al . Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.  Dig Liver Dis. 2007;  39 242-250
• 47 Loeve F, Brown M L, Boer R. et al . Endoscopic colorectal cancer screening: a cost-saving analysis.  J Natl Cancer Inst. 2000;  92 557-563